Cosmetic surgery across borders: what the evidence says about attracting international patients... and losing them

Who this is for

This is for the physician or medical professional who owns a cosmetic surgery practice, and/or the operations lead who handles its marketing and front desk. Some practices want patients from other countries. Others are watching their own patients book surgery overseas at a lower price.

Both questions sit in one market, so they share one body of evidence: how many patients travel and where, what happens to the ones who return with a problem, and whose advertising rules apply once an ad crosses a border.

Where do patients travel for cosmetic surgery, and what brings them back to a hospital at home?

The International Society of Aesthetic Plastic Surgery (ISAPS) counted 34.9 million aesthetic procedures worldwide in 2023, more than 15.8 million of them surgical. Its press release puts the rise over the previous four years at 40%.¹

The 2023 release names Colombia, Mexico, Turkey, Syria and Thailand as the countries with the highest average proportion of foreign patients.¹ The 2021 survey named Turkey, Colombia, Mexico and Thailand.²

ISAPS builds these totals from a questionnaire answered by plastic surgeons. Data from 1,003 of them went into the 2021 survey, compiled by an outside research firm, Industry Insights. The foreign-patient rankings come with no percentages attached.²

The published record of what happens next comes from hospitals at home that treated patients after surgery elsewhere. Six such studies are below, from the UK, Switzerland and the US.

The largest is British. Goodarzi and colleagues, in the Aesthetic Surgery Journal in 2026, analyzed all 198 cases reported to the British Association of Aesthetic Plastic Surgeons (BAAPS) cosmetic tourism complications database between September 2022 and September 2024. Seventy-six percent of those patients had their surgery in Turkey.³

Abdominoplasty (a tummy tuck) was the most common procedure, at 45%. Wound dehiscence, a surgical wound reopening, appeared in 37% of cases, infection in 28%, seroma in 24% and tissue necrosis in 20%. Nearly half, 48%, needed an operation under general anesthesia, 4% needed intensive care, and one patient died of a pulmonary embolism.³

The authors tied recurring problems to inadequate aftercare (21% of cases), poor preparation before surgery (12%) and flying home too soon (5%).³

A London teaching hospital reported 24 patients who needed surgery for complications between 2006 and 2018 (Thacoor and colleagues, 2019). Infection was the primary complication in 92% of them, and Turkey was the most common destination, at 29%.⁴

At University Hospital Zurich, Klein and colleagues found 109 patients with complications from cosmetic surgery abroad between 2010 and 2014. Infection was the main complication, at 25.7%. About a third, 34.8%, were admitted, for a mean of 5.2 days.⁵

In the Bronx, a 36-month review at Montefiore Medical Center found 42 patients, abdominoplasty the most common procedure (Adabi and colleagues, 2017).⁶ The American Society of Plastic Surgeons (ASPS), reporting the study, said 30 of the 42 had infection as at least one complication, 20 were admitted, and 13 needed surgery.⁷

In Boston, Ross and colleagues identified 78 patients over seven years, 59 of whom had travelled to the Dominican Republic. Surgical-site infection and pain were the most common complications, 14 patients each.⁸

At the Medical College of Wisconsin in Milwaukee, Venditto and colleagues treated 16 patients, and infection was the most common complication.⁹

Infection leads or comes near the top in every series. It was the main complication in London, Zurich, Milwaukee and the Bronx, tied with pain in Boston, and second to wound dehiscence in the BAAPS database. Abdominoplasty recurs too: it was the most common procedure in the BAAPS database and at Montefiore, and the most common source of complications in Boston.^3,4,5,7,8,9

Turkey appears on both sides of the record. ISAPS lists it among the countries with the highest share of foreign patients in 2021 and 2023, and 76% of the BAAPS cases and 29% of the London cases had surgery there. That overlap is our reading of separate sources, which measure different things.^1,2,3,4

Every one of these counts starts with a patient who came back with a problem and sought care. Patients who travelled and healed never enter the data, so none of the data points is a complication rate for surgery abroad.

What does treating those complications cost at home, and who pays?

The cost data points come from the treating hospitals, each in its own country, currency and year, so they do not add up or compare with one another. None is a price a patient paid for surgery. The costs fall on the health service, public insurers and the surgeons doing the repair, and in the one study that reports it, very little on the patient.

In the UK, Goodarzi and colleagues estimated the cost to the National Health Service (NHS) of treating the BAAPS cases, in pounds: £5,883 to £9,328 per patient, or £1.2 million to £1.8 million for the 198 cases over two years.³

The London series is also an NHS hospital, but its study reports the hospital's own treatment cost in US dollars: $406,233 in total for 24 patients, a mean of $16,296 per patient and a range of $817 to $41,778. Abdominoplasty complications cost the most, $20,404 per patient.⁴

In Milwaukee, Venditto and colleagues put the mean cost of treatment per patient at $26,657.19, from $392 for a single outpatient visit to $154,700.79 for a long admission with surgery. Of what was billed, the hospital retained 63% and the physicians 9%. The most any single patient paid was $2,635, by a patient with private insurance.⁹

In the Bronx, the Montefiore team put the mean cost of treating the complications at $18,211, with Medicaid the main payer.⁶ From that series they estimated a cost of $1.33 billion to the US health system, which the ASPS release gives as a yearly data point. The release says the researchers conservatively estimate about $730 million a year paid by Medicaid, $360 million by commercial insurance and $120 million by Medicare. All of it is extrapolated from one hospital's 42 patients.⁷

In Boston, 67 of the 78 patients relied on medical insurance for their follow-up care, 48 of them on Massachusetts Medicaid.⁸

Zurich is the exception in the set. Klein and colleagues found that Swiss diagnosis-based reimbursement roughly covered the hospital's total costs, and the abstract gives no amount.⁵

Two of the studies name price as the reason patients travel, and none records what patients paid abroad. Thacoor and colleagues attribute the trend to lower costs and all-inclusive surgery holiday packages⁴, and Venditto and colleagues to lower prices, shorter waiting lists and affordable travel.⁹

The Montefiore patients overestimated the US cost of their surgery by about $9,000, the ASPS release says, measured against average costs ASPS reports. That is the patients' own estimate set against the society's US data point, and the release does not say whether those averages are the surgeon's fee alone or the whole bill.⁷

Whose advertising rules apply when a practice markets across borders?

None of what follows is legal advice. It quotes each regulator's or platform's own text, and a practice advertising into another country needs a lawyer licensed there.

In the United States, Section 5 of the Federal Trade Commission Act declares unfair or deceptive acts or practices in commerce unlawful. The statute extends that to acts involving foreign commerce that cause, or are likely to cause, reasonably foreseeable injury within the United States.¹⁰

The FTC's Endorsement Guides, revised in 2023, define "product" to include any service. A consumer testimonial about a central attribute will likely be read as showing what consumers generally achieve, so the advertiser needs substantiation for that. The Guides add that consumer endorsements are not themselves competent and reliable scientific evidence.¹¹

In the United Kingdom, the CAP Code, which the Advertising Standards Authority (ASA) enforces, covers paid-for marketing on websites, apps and cross-border platforms when the marketer targets people in the UK. Rule 12.1 says objective claims must be backed by evidence. Rule 12.25 says marketing for cosmetic interventions must not be directed at people under 18 through the media or context it appears in.¹²

The ASA announced the under-18 rule in November 2021 and it took effect on 25 May 2022. Ads for cosmetic interventions may not appear in non-broadcast media directed at under-18s, or in other non-broadcast media where under-18s make up over 25% of the audience.¹³

Two ASA rulings from 2022 show how it reads its responsibility rule, 1.3. Linia Cosmetic Surgery breached it by calling breast augmentation "an easy process", and by a post saying breasts looked "perkier, fuller and younger", which the ASA said exploited insecurities about aging. A third Linia post, a Christmas discount with six weeks to respond, was not found in breach.¹⁴ A hospital group breached the same rule with an Instagram post offering Black Friday prices on breast surgery and the line "there is no better time", which the ASA found created undue urgency.¹⁵

In Dubai, the Dubai Health Authority's standard for medical advertising on social media, issued in 2022, applies to DHA-licensed facilities and professionals. A facility's official account must show the medical advertisement license number issued by the UAE Ministry of Health and Prevention. Before-and-after images should show the same person with the same lens and no photo editing, with a statement that the result is not guaranteed and may vary, plus the risks. Ads for surgical or invasive procedures need a clearly visible warning statement.¹⁶

The DHA standard addresses only DHA-licensed providers. It says nothing about a practice licensed elsewhere that advertises to people in Dubai.¹⁶

In China, the Advertising Law of the People's Republic of China applies to commercial advertising within China's territory. Article 16 bars medical advertisements from containing assertions or guarantees of efficacy or safety, cure or effectiveness rates, comparisons with other medical institutions, and recommendations or testimonials from endorsers. Article 46 requires medical ads to be reviewed by the relevant authority before publication, and an ad that has not been reviewed may not run.¹⁷

The platforms carry rules of their own. Google classes invasive medical procedures, cosmetic surgery included, as a sensitive health category for personalized ads: advertiser-curated audiences cannot be used, and users under 18 are not eligible for personalized ads of any kind.¹⁸ Meta requires ads for cosmetic procedures or surgeries to be targeted to people at least 18 years old, and bars ads that imply or try to generate negative self-perception.¹⁹

Who has measured whether marketing brings international patients in?

The only data points specific to medical tourism marketing come from an agency selling it. Lein Digital, which names itself among Turkey's medical tourism marketing agencies, reports case results on its own page.²⁰

For Apera Health, it says a Meta, Google Search and WhatsApp funnel aimed at patients in Romania, the UK, Germany and New Zealand cut cost per lead by 30% and lifted appointment conversions by 52% in three months. For Vialife Clinic, it reports organic traffic up 180%, leads up 65% and cost per acquisition down 40%.²⁰

We sell digital marketing too. The page gives no starting numbers, no spend, no sample sizes and no dates. A 180% gain on a small base can be a small absolute change.

What can a practice control when its patients compare it with surgery abroad?

Patients name lower prices as the reason they travel, and the Montefiore patients thought US surgery cost about $9,000 more than the ASPS averages. A clearly published price is one thing a practice controls.

Aftercare is another: the BAAPS authors tied 21% of cases to inadequate aftercare and 5% to flying home too soon.

A practice courting patients abroad answers to the rules where its ads land, and those rules differ in kind: a license number in Dubai, review before publication in China, audience limits in the UK. Every age rule quoted here draws the line at 18.

Each practice has a patient mix and a set of markets that no outside study sees, so these are starting points to test against a practice's own numbers.

About this review

We read the ISAPS global survey releases for 2021 and 2023, six peer-reviewed hospital studies (four in the Aesthetic Surgery Journal and two in Plastic and Reconstructive Surgery, dated 2017 to 2026) and the ASPS press release on the Montefiore study. Journal data points come from each study's published abstract on PubMed. The rules come from the US Code, the FTC Endorsement Guides on eCFR, the CAP Code (Edition 12) with the ASA's announcement and two rulings, the DHA social media standard, the Chinese Advertising Law as published on China's central government website, and Google's and Meta's own policy pages, all read in October 2026. The agency data points are the agency's own claims.

Every complication study counts only patients who returned for care, from single hospitals or one reporting database, and none measures how many patients a practice loses or what they paid abroad. The national cost data points are estimates. The Boston abstract gives the Dominican Republic count as 59 patients; the ASPS release for that study gives it as 59%. China's separate Measures for the Administration of Medical Advertisements are not quoted, and neither is any UAE federal rule beyond the license number the DHA standard names.

This review is not legal advice.

Fractional Aesthetics is a growth strategy practice for aesthetic medical businesses.